tiprankstipranks
Advertisement
Advertisement
David Roman Reiterates Sell on HealthEquity as Elevated Expectations and Valuation Skew Risk‑Reward to the Downside
PremiumRatingsDavid Roman Reiterates Sell on HealthEquity as Elevated Expectations and Valuation Skew Risk‑Reward to the Downside
1M ago
HealthEquity price target raised to $125 from $115 at BofA
Premium
The Fly
HealthEquity price target raised to $125 from $115 at BofA
1M ago
HealthEquity reports Q1 EPS $1.24, consensus $1.11
Premium
The Fly
HealthEquity reports Q1 EPS $1.24, consensus $1.11
1M ago
Optum acquisition not near-term threat to HealthEquity, says BofA
PremiumThe FlyOptum acquisition not near-term threat to HealthEquity, says BofA
3M ago
HealthEquity management to meet with KeyBanc
Premium
The Fly
HealthEquity management to meet with KeyBanc
3M ago
HealthEquity upgraded to Outperform from Market Perform at BMO Capital
Premium
The Fly
HealthEquity upgraded to Outperform from Market Perform at BMO Capital
3M ago
HealthEquity Inc. Earnings Call Highlights Profitable Growth
PremiumCompany AnnouncementsHealthEquity Inc. Earnings Call Highlights Profitable Growth
4M ago
HealthEquity: Strong Operational Execution and HSA Market Leadership Support Buy Rating and Upside to $110 Target
Premium
Ratings
HealthEquity: Strong Operational Execution and HSA Market Leadership Support Buy Rating and Upside to $110 Target
4M ago
HealthEquity price target lowered to $110 from $125 at Barrington
Premium
The Fly
HealthEquity price target lowered to $110 from $125 at Barrington
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100